New drug candidate will help people lose weight in an easier way, Zealand Pharma CEO says

Zealand Pharma CEO Adam Steensberg discusses the company’s new collaboration and licensing agreement with Roche as well as the commercial opportunities for its amylin analog molecule.

featured-image

Zealand Pharma CEO Adam Steensberg discusses the company’s new collaboration and licensing agreement with Roche as well as the commercial opportunities for its amylin analog molecule..